Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: HF Tissue Registry

View source ↗

Summary

The HF Tissue Registry trial (NCT02683681) is currently enrolling by invitation. Sponsored by Intermountain Health Care, Inc., the study targets heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Heart Failure | Status: ENROLLING_BY_INVITATION